Bio-Rad Laboratories (BIO-B) Inventory (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Inventory data on file, last reported at $770.5 million in Q1 2026.

• Quarterly Inventory fell 2.48% year-over-year to $770.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $770.5 million (down 2.48% YoY) and the FY2025 annual result came in at $740.7 million, down 2.54% from the prior year.
• Inventory rose to $770.5 million in Q1 2026 per BIO-B's latest filing, from $740.7 million in the prior quarter.
• Across five years, Inventory topped out at $804.3 million in Q3 2024 and bottomed at $605.5 million in Q1 2022.
• The 5-year median for Inventory is $775.8 million (2023), against an average of $752.3 million.
• The widest annual swing landed in 2022, when Inventory increased 25.7%; it then dropped 2.63% in 2024.
• Tracing BIO-B's Inventory over 5 years: stood at $719.3 million in 2022, then increased by 8.51% to $780.5 million in 2023, then declined by 2.63% to $760.0 million in 2024, then declined by 2.54% to $740.7 million in 2025, then climbed by 4.02% to $770.5 million in 2026.
• Per Business Quant, the three latest BIO-B Inventory figures stand at $770.5 million (Q1 2026), $740.7 million (Q4 2025), and $783.2 million (Q3 2025).

Peer Comparison